CVE-2017-5149
This may allow a man-in-the-middle attacker to access or influence communications between the identified endpoints.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (1.24%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
An issue was discovered in St. Jude Medical Merlin@home, versions prior to Version 8.2.2 (RF models: EX1150; Inductive models: EX1100; and Inductive models: EX1100 with MerlinOnDemand capability). The identities of the endpoints for the communication channel between the transmitter and St. Jude Medical's web site, Merlin.net, are not verified. This may allow a man-in-the-middle attacker to access or influence communications between the identified endpoints.
- CVSS 3.1
- 8.9 HIGHCVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:C/C:L/I:H/A:H
- EPSS
- 1.24% probability · 67th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-476
- Affected
- abbott/merlin\@home firmware
- Source
- ics-cert@hq.dhs.gov
References
- http://www.securityfocus.com/bid/95331Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-009-01AMitigation, Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/95331Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-17-009-01AMitigation, Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.